| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2019 | MEDP Medpace Holdings, Inc. | Geiger Jesse J60 | CFO &COO, Lab Operations | Sell | 31,348 | $83.08 | $2,604,432.00 | -64.9% | |
| Dec 20, 2019 | A Agilent Technologies, Inc. | McMullen Michael R.63 | CEO And President | Sell | 24,636 | $85.00 | $2,094,060.00 | -4.3% | |
| Dec 19, 2019 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.48 | $148,228.50 | - | |
| Dec 19, 2019 | GH Guardant Health, Inc. | Talasaz Amirali | Chairman, President And COO | Sell | 247,919 | $80.71 | $20,009,043.36 | -2.3% | |
| Dec 19, 2019 | GH Guardant Health, Inc. | Wiley Michael J | Chief Legal Officer | Sell | 43,000 | $79.68 | $3,426,321.52 | -9.5% | |
| Dec 18, 2019 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 150,000 | $1.50 | $224,750.00 | - | |
| Dec 17, 2019 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 75,000 | $1.54 | $115,375.00 | - | |
| Dec 17, 2019 | RDNT Radnet, Inc. | Hames Norman R56 | President, Western Operations | Sell | 10,327 | $18.92 | $195,435.74 | -1.0% | |
| Dec 17, 2019 | VCYT Veracyte, Inc. | Jones Evan/ Fa70 | Director | Sell | 15,000 | $29.26 | $438,865.50 | -8.6% | |
| Dec 16, 2019 | RDNT Radnet, Inc. | Villigerwilson Ruth Louisa51 | SVP Human Resources | Sell | 3,254 | $0.00 | - | -17.6% | |
| Dec 13, 2019 | MYGN Myriad Genetics Inc | Gilbert Walter Phd | Director | Buy | 5,860 | $25.60 | $149,997.83 | +12.1% | |
| Dec 13, 2019 | RDNT Radnet, Inc. | Hames Norman R56 | President, Western Operations | Sell | 9,673 | $19.62 | $189,784.26 | -1.8% | |
| Dec 12, 2019 | A Agilent Technologies, Inc. | Grau Dominique70 | Senior Vice President | Sell | 7,712 | $84.00 | $647,808.00 | -7.3% | |
| Dec 12, 2019 | A Agilent Technologies, Inc. | Doak Mark | Sr. Vice President | Sell | 8,016 | $84.50 | $677,385.67 | -5.3% | |
| Dec 12, 2019 | GH Guardant Health, Inc. | Meresman Stanley J75 | Director | Sell | 5,000 | $71.50 | $357,500.00 | -79.3% | |
| Dec 11, 2019 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.50 | $150,171.99 | - | |
| Dec 11, 2019 | A Agilent Technologies, Inc. | Grau Dominique70 | Senior Vice President | Sell | 15,000 | $82.85 | $1,242,690.00 | -13.3% | |
| Dec 10, 2019 | NEO Neogenomics Inc | McKenzie Kathryn B | Chief Accounting Officer | Sell | 8,000 | $26.37 | $210,960.00 | -77.9% | |
| Dec 10, 2019 | A Agilent Technologies, Inc. | Tang Michael61 | SVP, General Counsel, And Sec. | Sell | 3,364 | $82.90 | $278,875.60 | -4.2% | |
| Dec 10, 2019 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Chairman And CEO | Sell | 20,000 | $28.96 | $579,248.00 | -16.3% | |
| Dec 10, 2019 | A Agilent Technologies, Inc. | McMullen Michael R.63 | CEO And President | Sell | 49,272 | $81.45 | $4,013,204.40 | -4.3% | |
| Dec 9, 2019 | CRL Charles River Laboratories International, Inc. | Johst David P | Corporate Executive VP | Sell | 24,660 | $144.21 | $3,556,341.22 | -0.4% | |
| Dec 9, 2019 | CRL Charles River Laboratories International, Inc. | Girshick Birgit65 | Corporate Executive VP | Sell | 1,051 | $145.55 | $152,971.70 | -0.4% | |
| Dec 9, 2019 | CRL Charles River Laboratories International, Inc. | Girshick Birgit65 | Corporate Executive VP | Sell | 2,874 | $144.93 | $416,516.02 | -0.5% | |
| Dec 9, 2019 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 50,000 | $1.59 | $79,500.00 | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.